Bemarituzumab (Anti-FGFR2 / CD332)
Product Specifications
CAS Number
1952272-74-0
SKU
C00296-1mg
Target
FGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Bemarituzumab (Anti-FGFR2 / CD332) is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor) . Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research. MW: 145.24 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP317831 20 µg
MIA40 (CHCHD4) (NM_001098502) Human Recombinant Protein
Sign In for Pricing
View Details 
